AbTx raises $2.0M
AbTx announced a Seed round of $2.0M on 16 September 2026. The company operates in HealthTech and is based in France. It was founded by Meddy El Alaoui, CEO. Announced 5 days ago.
Founder
Outreach angles
- -El Alaoui announced on LinkedIn that he had taken on the CEO role at AbTx after previously working in bioproduction and biotherapies.
- -He has spoken publicly at France 2030 events on biotherapies and bioproduction policy.
- -The 1.7 million euro seed round helps AbTx push its drug-conjugated immunotherapy for resistant tumors from Dijon toward clinical development.
Signals
SeedHealthcareDeep TechB2BRegulated Industry
Round details
Company: AbTx
Domain: abtx-bio.com
Amount: $2.0M
Stage: Seed
Industry: HealthTech
Country: France
Announced: 16 September 2026
Other HealthTech raises
Recently funded in France